A099430 Stock Overview
Engages in the research and development, production, and sale of bio products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Bio Plus Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,580.00 |
| 52 Week High | ₩9,090.00 |
| 52 Week Low | ₩4,250.00 |
| Beta | 0.68 |
| 11 Month Change | 21.57% |
| 3 Month Change | -18.54% |
| 1 Year Change | -22.28% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.22% |
Recent News & Updates
More Unpleasant Surprises Could Be In Store For Bio Plus Co., Ltd's (KOSDAQ:099430) Shares After Tumbling 31%
Jun 08
Additional Considerations Required While Assessing Bio Plus' (KOSDAQ:099430) Strong Earnings
Mar 26Shareholder Returns
| A099430 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 9.8% | -3.9% | 0.2% |
| 1Y | -22.3% | 7.5% | 7.1% |
Return vs Industry: A099430 underperformed the KR Medical Equipment industry which returned 11.1% over the past year.
Return vs Market: A099430 underperformed the KR Market which returned 7.4% over the past year.
Price Volatility
| A099430 volatility | |
|---|---|
| A099430 Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A099430 has not had significant price volatility in the past 3 months.
Volatility Over Time: A099430's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 84 | Hyun-Kyu Jung | www.ubioplus.co.kr |
Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms.
Bio Plus Co., Ltd Fundamentals Summary
| A099430 fundamental statistics | |
|---|---|
| Market cap | ₩319.11b |
| Earnings (TTM) | ₩21.79b |
| Revenue (TTM) | ₩62.25b |
14.6x
P/E Ratio5.1x
P/S RatioIs A099430 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A099430 income statement (TTM) | |
|---|---|
| Revenue | ₩62.25b |
| Cost of Revenue | ₩24.61b |
| Gross Profit | ₩37.63b |
| Other Expenses | ₩15.85b |
| Earnings | ₩21.79b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 380.97 |
| Gross Margin | 60.46% |
| Net Profit Margin | 35.00% |
| Debt/Equity Ratio | 8.4% |
How did A099430 perform over the long term?
See historical performance and comparison